253 related articles for article (PubMed ID: 33185939)
1. Aberrant expression of junctional adhesion molecule-A contributes to the malignancy of cervical adenocarcinoma by interaction with poliovirus receptor/CD155.
Murakami T; Takasawa A; Takasawa K; Akimoto T; Aoyama T; Magara K; Saito Y; Ota M; Kyuno D; Yamamoto S; Hasegawa T; Saito T; Osanai M
Cancer Sci; 2021 Feb; 112(2):906-917. PubMed ID: 33185939
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the expression and localization of tight junction transmembrane proteins, claudin-1, -4, -7, occludin and JAM-A, in human cervical adenocarcinoma.
Akimoto T; Takasawa A; Murata M; Kojima Y; Takasawa K; Nojima M; Aoyama T; Hiratsuka Y; Ono Y; Tanaka S; Osanai M; Hasegawa T; Saito T; Sawada N
Histol Histopathol; 2016 Aug; 31(8):921-31. PubMed ID: 26847087
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of JAM-A promotes neoplastic properties of lung adenocarcinoma.
Magara K; Takasawa A; Osanai M; Ota M; Tagami Y; Ono Y; Takasawa K; Murata M; Hirohashi Y; Miyajima M; Yamada G; Hasegawa T; Sawada N
Cancer Sci; 2017 Nov; 108(11):2306-2314. PubMed ID: 28837251
[TBL] [Abstract][Full Text] [Related]
4. Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling.
Brennan K; McSherry EA; Hudson L; Kay EW; Hill AD; Young LS; Hopkins AM
Oncogene; 2013 May; 32(22):2799-804. PubMed ID: 22751120
[TBL] [Abstract][Full Text] [Related]
5. Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer.
Fong D; Spizzo G; Mitterer M; Seeber A; Steurer M; Gastl G; Brosch I; Moser P
Ann Surg Oncol; 2012 Dec; 19(13):4330-6. PubMed ID: 22549289
[TBL] [Abstract][Full Text] [Related]
6. Junctional adhesion molecule A [corrected] expression in human endometrial carcinoma.
Koshiba H; Hosokawa K; Kubo A; Tokumitsu N; Watanabe A; Honjo H
Int J Gynecol Cancer; 2009 Feb; 19(2):208-13. PubMed ID: 19395995
[TBL] [Abstract][Full Text] [Related]
7. Low junctional adhesion molecule A expression correlates with poor prognosis in gastric cancer.
Huang JY; Xu YY; Sun Z; Wang ZN; Zhu Z; Song YX; Luo Y; Zhang X; Xu HM
J Surg Res; 2014 Dec; 192(2):494-502. PubMed ID: 25033702
[TBL] [Abstract][Full Text] [Related]
8. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
[TBL] [Abstract][Full Text] [Related]
9. Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settings.
Leech AO; Vellanki SH; Rutherford EJ; Keogh A; Jahns H; Hudson L; O'Donovan N; Sabri S; Abdulkarim B; Sheehan KM; Kay EW; Young LS; Hill ADK; Smith YE; Hopkins AM
Breast Cancer Res; 2018 Nov; 20(1):140. PubMed ID: 30458861
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of JAM-A plays an important role in human tumor progression.
Zhao C; Lu F; Chen H; Zhao X; Sun J; Chen H
Int J Clin Exp Pathol; 2014; 7(10):7242-8. PubMed ID: 25400822
[TBL] [Abstract][Full Text] [Related]
12. CD155, an onco-immunologic molecule in human tumors.
Gao J; Zheng Q; Xin N; Wang W; Zhao C
Cancer Sci; 2017 Oct; 108(10):1934-1938. PubMed ID: 28730595
[TBL] [Abstract][Full Text] [Related]
13. Characterization and identification of Tage4 as the murine orthologue of human poliovirus receptor/CD155.
Ravens I; Seth S; Förster R; Bernhardt G
Biochem Biophys Res Commun; 2003 Dec; 312(4):1364-71. PubMed ID: 14652024
[TBL] [Abstract][Full Text] [Related]
14. The F11 Receptor (F11R)/Junctional Adhesion Molecule-A (JAM-A) (F11R/JAM-A) in cancer progression.
Czubak-Prowizor K; Babinska A; Swiatkowska M
Mol Cell Biochem; 2022 Jan; 477(1):79-98. PubMed ID: 34533648
[TBL] [Abstract][Full Text] [Related]
15. Analysis of poliovirus receptor, CD155 expression in different human colorectal cancer cell lines: Implications for poliovirus virotherapy.
Zhand S; Hosseini SM; Tabarraei A; Moradi A; Saeidi M
J Cancer Res Ther; 2019; 15(1):61-67. PubMed ID: 30880756
[TBL] [Abstract][Full Text] [Related]
16. Junctional adhesion molecule-A is down-regulated in anaplastic thyroid carcinomas and reduces cancer cell aggressiveness by modulating p53 and GSK3 α/β pathways.
Orlandella FM; Mariniello RM; Iervolino PLC; Auletta L; De Stefano AE; Ugolini C; Greco A; Mirabelli P; Pane K; Franzese M; Denaro M; Basolo F; Salvatore G
Mol Carcinog; 2019 Jul; 58(7):1181-1193. PubMed ID: 30834573
[TBL] [Abstract][Full Text] [Related]
17. Recruitment of nectin-3 to cell-cell junctions through trans-heterophilic interaction with CD155, a vitronectin and poliovirus receptor that localizes to alpha(v)beta3 integrin-containing membrane microdomains.
Mueller S; Wimmer E
J Biol Chem; 2003 Aug; 278(33):31251-60. PubMed ID: 12759359
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-374b inhibits cervical cancer cell proliferation and induces apoptosis through the p38/ERK signaling pathway by binding to JAM-2.
Li GC; Cao XY; Li YN; Qiu YY; Li YN; Liu XJ; Sun XX
J Cell Physiol; 2018 Sep; 233(9):7379-7390. PubMed ID: 29575013
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β1 attenuates junctional adhesion molecule-A and contributes to breast cancer cell invasion.
Wang Y; Lui WY
Eur J Cancer; 2012 Dec; 48(18):3475-87. PubMed ID: 22647687
[TBL] [Abstract][Full Text] [Related]
20. Aldolase A promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma.
Saito Y; Takasawa A; Takasawa K; Aoyama T; Akimoto T; Ota M; Magara K; Murata M; Hirohashi Y; Hasegawa T; Sawada N; Saito T; Osanai M
Cancer Sci; 2020 Aug; 111(8):3071-3081. PubMed ID: 32530543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
